Cormorant Asset Management, LP, 10% Owner at EyePoint Pharmaceuticals, Inc. (EYPT), bought 855,000 shares at $21.32 ($17.1M) on 2024-01-09, disclosed to the SEC on 2024-01-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.32 | 105,000 | $2.2M | 13.1% |
| 2 | $19.75 | 750,000 | $14.8M | 86.9% |
| Total | $19.94 avg | 855,000 | $17.1M | 100% |
| Filing → |
| DRUG | BUY | 2024-11-06 | $8.0M | — | Filing → |
| EYPT | BUY | 2024-05-08 | $20.2M | — | Filing → |
| CRBP | BUY | 2024-02-06 | $14.3M | — | Filing → |